Pathophysiology of Non-Hodgkin's Lymphoma

Paper Summary:

This paper is a brief examination of the pathophysiology of Non-Hodgkin's Lymphoma, its etiology and sites a few statistics. The focus of this paper is on phiological component of the disease rather than presenting symptoms or treatment. Additionally, the paper further discusses genetic research into lymphomas as the key to finding a cure.

From the Paper:

"Non-Hodgkin's lymphoma (NHL) is the sixth most common cancer and the sixth most common cause of cancer death. It is generally estimated that there are 55,000 new cases of non-Hodgkin's lymphoma diagnosed annually in the U.S. alone, although recent estimates are as high as 80,000 ("Large Scale Biology Corporation," 2002). Of the wide variety of Non-Hodgkin's Lymphoma's, B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL), mantle cell lymphoma (MCL) and grades I and II follicular lymphoma (FLI/FLII) constitute one third of all NHL cases (Guo, Burger, Nimmrich, Maier, Becker, Duff, Rahmatpanah, Chitma-Matsiga, Shi, Berlin, Huang & Caldwell, 2005). This paper will focus on the various genetic and cellular level abnormalities that occur with NHLs."

More papers on Pathophysiology of Non-Hodgkin's Lymphoma:

• Research Paper # 120343 : "Treatment for Non-Hodgkin's Lymphoma"
• Research Paper # 58600 : "Non-Hodgkin's Lymphoma"
• Term Paper # 104727 : "Non-Hodgkin's Lymphoma"

APA Citation:

MLA Citation: